MedPath

To compare the effectiveness of homoeopathic remedy in centesimal potency and 50 millesimal potency for irritable bowel syndrome.

Phase 2
Conditions
Health Condition 1: K58- Irritable bowel syndrome
Registration Number
CTRI/2024/06/069214
Lead Sponsor
ational Institute of Homoeopathy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a. Patients suffering from IBS as per Rome IV diagnostic criteria

b. Both sexes

c. Age 18-65 years

d. Patients willing to participate in the study and giving written informed consent.

e. Ability to Understand Bengali or Hindi or English

Exclusion Criteria

a. Any major gastrointestinal surgery in the last 6 months

b. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life threatening illness affecting the quality of life or any organ failure.

c. Currently receiving standard therapy for IBS and/ or homoeopathic treatment for any

chronic condition(s)

d. Pregnant and lactating women

e. Self-reported immune compromised conditions

f. Substance abuse and/or dependence

g. Patients who are too sick for consultation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath